Ugo Cavallaro , Marco R. Soria , Roberto Montesano
{"title":"Exogenous Fibroblast Growth Factor-2 Induces a Transformed Phenotype in Vascular Kaposi's Sarcoma-like Cells","authors":"Ugo Cavallaro , Marco R. Soria , Roberto Montesano","doi":"10.1006/mcbr.2001.0278","DOIUrl":"10.1006/mcbr.2001.0278","url":null,"abstract":"<div><p>Vascular TTB cells derive from murine Kaposi's sarcoma-like dermal lesions and share several phenotypic features with AIDS-associated KS spindle cells. We have recently reported that fibroblast growth factor-2 (FGF-2) promotes dramatic cytoskeletal and morphological alterations in TTB cells, concomitant with the induction of an autocrine loop for hepatocyte growth factor and a relocalization of the urokinase receptor. Since all these alterations are hallmarks of cell transformation. we attempted to verify whether FGF-2 induces a transformed phenotype in TTB cells. Our results show that FGF-2-treated TTB cells acquire the ability to grow under anchorage-independent conditions. In addition, FGF-2 markedly reduced the levels of thrombospondin-1, an antiangiogenic and tumor suppressor protein, in TTB cells. Therefore, FGF-2 induces KS-like spindle cells to acquire properties characteristic of transformed cells. This suggests that FGF-2 plays a pathogenetic role in KS not only by promoting angiogenesis, but also by conferring a transformed phenotype upon KS cells. In light of previous reports on Tat-induced release of FGF-2 into the extracellular space, our findings may provide an additional mechanism for the observed synergism between Tat and FGF-2 in the pathogenesis of KS.</p></div>","PeriodicalId":80086,"journal":{"name":"Molecular cell biology research communications : MCBRC","volume":"4 4","pages":"Pages 203-205"},"PeriodicalIF":0.0,"publicationDate":"2000-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1006/mcbr.2001.0278","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82406852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Inflammation and Interleukin-6 Mediate Reductions in the Hepatic Expression and Transcription of the mdr1a and mdr1b Genes","authors":"Mahadeo Sukhai, Adriane Yong, Julie Kalitsky, Micheline Piquette-Miller","doi":"10.1006/mcbr.2001.0288","DOIUrl":"https://doi.org/10.1006/mcbr.2001.0288","url":null,"abstract":"<div><p>In order to elucidate the mechanisms involved in the downregulation of mdr 1 gene expression reported in experimentally-induced inflammation, we examined the effects of experimentally-induced inflammation and interleukin-(IL-) 6 on transcriptional control of the <em>mdr1</em> genes in rats. RNA, nuclear extracts, and nuclear protein fractions were isolated from livers harvested from saline or turpentine-treated male Sprague–Dawley rats or from IL-6 treated or nontreated (controls) cultured rat hepatocytes. <em>mdr</em> gene expression and regulation was examined by RT-PCR, mRNA stability studies, nuclear run-on analysis of transcription, and gel shift analysis of promoter-transcription factor interaction. As compared to controls, significantly lower levels of <em>mdr1a</em> and <em>mdr1b</em> mRNA and significantly decreased <em>mdr1a</em> and <em>mdr1b</em> transcription rates were observed in livers isolated from the turpentine-treated rats. <em>In vitro</em> treatments of cultured hepatocytes with IL-6 also suppressed <em>mdr1a</em> and <em>mdr1b</em> mRNA expression and imposed similar reductions in <em>mdr1a</em> and <em>mdr1b</em> transcriptional activity. Significant effects of IL-6 on <em>mdr1</em> mRNA stability were not seen. Our results indicate that reductions in <em>mdr1</em> expression in experimental models of inflammation likely occurs through altered gene transcription. Furthermore, as IL-6 was found to decrease <em>mdr1</em> expression and gene transcription rates <em>in vitro,</em> this cytokine is likely involved in the reduction of <em>mdr1</em> expression that is seen <em>in vivo</em> during an acute inflammatory response.</p></div>","PeriodicalId":80086,"journal":{"name":"Molecular cell biology research communications : MCBRC","volume":"4 4","pages":"Pages 248-256"},"PeriodicalIF":0.0,"publicationDate":"2000-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1006/mcbr.2001.0288","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91635130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Genetic and molecular mechanisms of cell size control.","authors":"J. Montagne","doi":"10.1006/MCBR.2001.0284","DOIUrl":"https://doi.org/10.1006/MCBR.2001.0284","url":null,"abstract":"Since the discovery of the cell as the minimal indivisible living entity, scientists have tried to understand how all the various physiological aspects were assumed within this single functional unit. One fascinating question concerns the role of cell size and cell number in determining the overall size of an organism. During the past century, increasing knowledge in molecular genetics has allowed the characterization of a number of molecular events that influence the size of a cell. However, in spite of recent progress, precise molecular mechanisms governing cell size remain unclear. Although the existence of a master regulator is still possible, cell size may be primarily controlled by an interactive network linking gene expression with translational capacity and cell proliferation.","PeriodicalId":80086,"journal":{"name":"Molecular cell biology research communications : MCBRC","volume":"53 1","pages":"195-202"},"PeriodicalIF":0.0,"publicationDate":"2000-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90669840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Natalia Dolzhanskaya , James Conti , George Merz , Robert B. Denman
{"title":"In Vivo Ribozyme Targeting of βAPP+ mRNAs","authors":"Natalia Dolzhanskaya , James Conti , George Merz , Robert B. Denman","doi":"10.1006/mcbr.2001.0287","DOIUrl":"10.1006/mcbr.2001.0287","url":null,"abstract":"<div><p>In Alzheimer's disease (AD) and Down's syndrome (DS) patients, posttranscriptional alterations of sequences encoded by exon 9 and exon 10 of the β-amyloid precursor protein (βAPP) mRNA result in mutant proteins (βAPP<sup>+</sup>) that colocalize with neurofibrillary tangles and senile plaques. These aberrant messages may contribute to the development of sporadic or late-onset Alzheimer's disease; thus, eliminating them or attenuating their expression could significantly benefit AD patients. In the present work, self-cleaving hammerhead ribozymes targeted to βAPP exon 9 (Rz9) and βAPP<sup>+</sup> mutant exon 10 (Rz10) were examined for their ability to distinguish between βAPP and βAPP<sup>+</sup> mRNA. In transiently transfected A-204 cells, quantitative confocal fluorescence microscopy showed that Rz9 preferentially lowered endogenous βAPP. In contrast, in transient cotransfection experiments with βAPP<sup>+</sup> mRNAs containing a wild-type exon 9 and mutant exon 10 (βAPP-9/βAPP-10+1), or a mutant exon 9 and wild-type exon 10 (βAPP-9+1/βAPP-10) we found that Rz9 and Rz10 preferentially reduced βAPP<sup>+</sup>-mutant exon 10 mRNA in a concentration and a ribozyme-dependent manner.</p></div>","PeriodicalId":80086,"journal":{"name":"Molecular cell biology research communications : MCBRC","volume":"4 4","pages":"Pages 239-247"},"PeriodicalIF":0.0,"publicationDate":"2000-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1006/mcbr.2001.0287","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"51527381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"BAP37 and Prohibitin Are Specifically Recognized by an SV40 T Antigen Antibody","authors":"Alison J. Darmon , Parmjit S. Jat","doi":"10.1006/mcbr.2001.0281","DOIUrl":"10.1006/mcbr.2001.0281","url":null,"abstract":"<div><p>We have identified two cellular proteins that are specifically immunoprecipitated by an anti-SV40 T antigen monoclonal antibody. This antibody, PAb419, recognizes an epitope contained within a region of T antigen which we have recently demonstrated is required for the initiation of immortalization by SV40 T antigen, but is not essential for maintenance of the immortal state. The two proteins were identified as BAP37 and Prohibitin. Recent results suggest Prohibitin may enhance the transcriptional inactivation of E2F by the retinoblastoma family of pocket proteins (pRb, p107, p130). BAP37 and Prohibitin are specifically recognized by PAb419 and PAb210, another anti-SV40 T antigen monoclonal antibody, which has an overlapping epitope, but not by other anti-SV40 T antigen monoclonal antibodies, demonstrating the specificity of the interaction.</p></div>","PeriodicalId":80086,"journal":{"name":"Molecular cell biology research communications : MCBRC","volume":"4 4","pages":"Pages 219-223"},"PeriodicalIF":0.0,"publicationDate":"2000-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1006/mcbr.2001.0281","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83038314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Beatriz Levy-Wilson , Bernhard Paulweber , Travis J Antes , Sheryl A Goodart , Soon-Youl Lee
{"title":"An Open Chromatin Structure in a Liver-Specific Enhancer That Confers High Level Expression to Human Apolipoprotein B Transgenes in Mice","authors":"Beatriz Levy-Wilson , Bernhard Paulweber , Travis J Antes , Sheryl A Goodart , Soon-Youl Lee","doi":"10.1006/mcbr.2001.0279","DOIUrl":"https://doi.org/10.1006/mcbr.2001.0279","url":null,"abstract":"<div><p>A number of DNaseI-hypersensitive (DH) sites have been mapped within a regulatory region situated upstream of the human apolipoprotein B (apoB) promoter (−5262 to −899) that is required for high level expression of human apoB transgenes in the livers of mice. These DH sites were observed in nuclei from transcriptionally active liver-derived HepG2 cells, but were absent from transcriptionally inactive HeLa cell nuclei. Several nuclear protein binding sites were detected in the DNaseI-hypersensitive region by DNaseI footprinting with HepG2 nuclear extracts, representing putative binding sites for the liver-specific activators. The locations of binding sites for these transcription factors were revealed via computer analysis of the DNA sequence of this region against a transcription factor database. Many micrococcal nuclease hypersensitive (MH) sites were also observed in nuclei from HepG2 cells but not in HeLa cell nuclei, implying that in hepatic cells, nucleosomes are either absent or have been displaced from this region by the liver-specific transcriptional activators, as inferred by the correspondence between the DH sites, the MH sites and the footprints.</p></div>","PeriodicalId":80086,"journal":{"name":"Molecular cell biology research communications : MCBRC","volume":"4 4","pages":"Pages 206-211"},"PeriodicalIF":0.0,"publicationDate":"2000-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1006/mcbr.2001.0279","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91680525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Support vector machines for prediction of protein subcellular location.","authors":"Y. Cai, Xiao-Jun Liu, Xue-biao Xu, Kuo-Chen Chou","doi":"10.1006/MCBR.2001.0285","DOIUrl":"https://doi.org/10.1006/MCBR.2001.0285","url":null,"abstract":"Support Vector Machine (SVM), which is one kind of learning machines, was applied to predict the subcellular location of proteins from their amino acid composition. In this research, the proteins are classified into the following 12 groups: (1) chloroplast, (2) cytoplasm, (3) cytoskeleton, (4) endoplasmic reticulum, (5) extracall, (6) Golgi apparatus, (7) lysosome, (8) mitochondria, (9) nucleus, (10) peroxisome, (11) plasma membrane, and (12) vacuole, which have covered almost all the organelles and subcellular compartments in an animal or plant cell. The examination for the self-consistency and the jackknife test of the SVMs method was tested for the three sets: 2022 proteins, 2161 proteins, and 2319 proteins. As a result, the correct rate of self-consistency and jackknife test reaches 91 and 82% for 2022 proteins, 89 and 75% for 2161 proteins, and 85 and 73% for 2319 proteins, respectively. Furthermore, the predicting rate was tested by the three independent testing datasets containing 2240 proteins, 2513 proteins, and 2591 proteins. The correct prediction rates reach 82, 75, and 73% for 2240 proteins, 2513 proteins, and 2591 proteins, respectively.","PeriodicalId":80086,"journal":{"name":"Molecular cell biology research communications : MCBRC","volume":"1 1","pages":"230-3"},"PeriodicalIF":0.0,"publicationDate":"2000-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84700017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
B. Levy-Wilson, B. Paulweber, T. Antes, S. Goodart, S. Y. Lee
{"title":"An open chromatin structure in a liver-specific enhancer that confers high level expression to human apolipoprotein b transgenes in mice.","authors":"B. Levy-Wilson, B. Paulweber, T. Antes, S. Goodart, S. Y. Lee","doi":"10.1006/MCBR.2001.0279","DOIUrl":"https://doi.org/10.1006/MCBR.2001.0279","url":null,"abstract":"A number of DNaseI-hypersensitive (DH) sites have been mapped within a regulatory region situated upstream of the human apolipoprotein B (apoB) promoter (-5262 to -899) that is required for high level expression of human apoB transgenes in the livers of mice. These DH sites were observed in nuclei from transcriptionally active liver-derived HepG2 cells, but were absent from transcriptionally inactive HeLa cell nuclei. Several nuclear protein binding sites were detected in the DNaseI-hypersensitive region by DNaseI footprinting with HepG2 nuclear extracts, representing putative binding sites for the liver-specific activators. The locations of binding sites for these transcription factors were revealed via computer analysis of the DNA sequence of this region against a transcription factor database. Many micrococcal nuclease hypersensitive (MH) sites were also observed in nuclei from HepG2 cells but not in HeLa cell nuclei, implying that in hepatic cells, nucleosomes are either absent or have been displaced from this region by the liver-specific transcriptional activators, as inferred by the correspondence between the DH sites, the MH sites and the footprints.","PeriodicalId":80086,"journal":{"name":"Molecular cell biology research communications : MCBRC","volume":"148 1","pages":"206-11"},"PeriodicalIF":0.0,"publicationDate":"2000-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77898850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Fabio Favilli, Serena Catarzi, Teresa Iantomasi, Maria T Vincenzini
{"title":"Glutathione Transport System in NIH3T3 Fibroblasts","authors":"Fabio Favilli, Serena Catarzi, Teresa Iantomasi, Maria T Vincenzini","doi":"10.1006/mcbr.2001.0280","DOIUrl":"10.1006/mcbr.2001.0280","url":null,"abstract":"<div><p>The current study characterizes a mediated transport for GSH uptake in murine fibroblasts NIH3T3. The presence of GSH mediated transport is indicated by the behaviour of GSH uptake time-course, as well as by kinetic saturation and the specific inhibition of the initial rate of GSH transport. Moreover, a concentrative GSH uptake has been measured, whose driving force may be due to a change of membrane potential and the direct involvement of ATP. Hyperbolic kinetic saturation shows a single mediated transport with high affinity for GSH (<em>K</em><sub>m</sub> = 0.209 ± 0.03 mM). High specificity of this GSH transporter for the entire structure of GSH is also demonstrated. To summarize, GSH uptake into NIH3T3 cells occurs by an active transport system and shows characteristics similar to ATP-dependent mechanisms previously identified in hepatocyte membranes. Moreover, a possible physiological role of this GSH transporter related to NIH3T3 cell proliferation has been hypothesized.</p></div>","PeriodicalId":80086,"journal":{"name":"Molecular cell biology research communications : MCBRC","volume":"4 4","pages":"Pages 212-218"},"PeriodicalIF":0.0,"publicationDate":"2000-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1006/mcbr.2001.0280","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72498214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Oligomeric status of the dihydropyridine receptor in aged skeletal muscle.","authors":"M. Ryan, B. Carlson, K. Ohlendieck","doi":"10.1006/MCBR.2001.0282","DOIUrl":"https://doi.org/10.1006/MCBR.2001.0282","url":null,"abstract":"A prominent feature of aging is represented by a decrease in muscle mass and strength. Abnormalities in Ca2+ -regulatory membrane complexes are involved in many muscular disorders. In analogy, we determined potential age-related changes in a key component of excitation-contraction coupling, the dihydropyridine receptor. Immunoblotting of the microsomal fraction from aged rabbit muscle revealed a drastic decline in the voltage-sensing alpha1-subunit of this transverse-tubular receptor, but only marginally altered expression of its auxiliary alpha(2)-subunit and the Na+/K+ -ATPase. A shift to slower fibre type characteristics was indicated by an age-related increase in the slow calsequestrin isoform. Chemical crosslinking analysis showed that the triad receptor complex has a comparable tendency of protein-protein interactions in young and aged muscles. Hence, a reduced expression and not modified oligomerization of the principal dihydropyridine receptor subunit might be involved in triggering impaired triadic signal transduction and abnormal Ca2+ -homeostasis resulting in a progressive functional decline of skeletal muscles.","PeriodicalId":80086,"journal":{"name":"Molecular cell biology research communications : MCBRC","volume":"22 1","pages":"224-9"},"PeriodicalIF":0.0,"publicationDate":"2000-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82888575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}